Logo

American Heart Association

  21
  0


Final ID: MP1749

Identification of ECG Abnormalities up to Two Years Prior to Symptomatic Manifestation of Pediatric Pulmonary Arterial Hypertension: A Japanese Nationwide School Screening Study

Abstract Body (Do not enter title and authors here): Background: Idiopathic/heritable pulmonary arterial hypertension (I/H-PAH), a disease with poor prognosis, often faces diagnostic delays due to nonspecific initial symptoms. In Japan, school ECG screening, performed in every 3 years for all students, identifies 41% of school-aged I/H-PAH patients; these typically show elevated pulmonary artery pressure (PAP) but have minimal symptoms (WHO-FC I/II) and preserved RV function. In this disease, the duration from the appearance of pulmonary vascular lesions to PH manifestation and the subsequent onset of RV failure are unknown.
Objective: To address the precise pathological trajectory leading to PH manifestation, PH-related ECG findings at diagnosis (Dx) and pre-Dx in pediatric PAH patients were investigated utilizing Japan's school ECG screening system.
Methods: Observational study of I/H-PAH patients (6-18 years), newly diagnosed 2005-2020, in Japanese pediatric cardiology teaching hospitals. School ECGs at/pre Dx were evaluated for PH-related findings (R≥1.5mV in V1, RV strain, Q in V1, IRBBB, inverted T waves) according to the criteria from the Japanese Society of Pediatric Cardiology and Cardiac Surgery.
Results: In the survey, 118/143 institutions (82.5%) responded; 45 (38%) of those reported cases. 88 patients (51M, 37F; mean age 10.7y) were analyzed. Mode of detection of PAH were school ECG screening (n=36), symptoms (44), family history (5), and incidental findings (3). Compared to nonscreening group, the school screening group had higher proportion of WHO-FC I/II (91% vs 57%, p<.01) and lower plasma BNP (20 vs 102 pg/mL, p<.01), with comparable mean PAP (48 vs 55 mmHg, p=.65) and PVRI (12.1 vs 15.8 WU×m2, p=.38). PH-related ECG findings at Dx (n=87), which were present in 93% of all patients, were largely comparable between the groups (95% vs 91, p=.68), with the exception of higher prevalence of Q waves in V1 in the nonscreening (31% vs 15, p<.05) and R≥1.5mV in V1 in the screening group (59% vs 30, p<.05). Crucially, among 35 pre-Dx ECGs, PH-related abnormalities were observed in 77% (10/13) of those taken within 2 years of Dx, versus only 14% (3/22, p<.01) of those taken >2 years prior.
Conclusion: Pre-Dx ECG analysis indicates PH-related findings can appear up to 2 years before symptom manifestation, suggesting a 1-2 year window of established PH with minimal symptoms in many pediatric patients. This highlights the potential for earlier diagnosis by performing ECG screening at even shorter intervals.
  • Sawada, Hirofumi  ( MIE UNIVERSITY , Tsu Mie , Japan )
  • Sagawa, Koichi  ( Fukuoka Children's Hospital , Fukuoka , Japan )
  • Muneuchi, Jun  ( Kyushu Hospital , Kitakyushu , Japan )
  • Nakayama, Tomotaka  ( Toho University Omori Medical Cente , Tokyo , Japan )
  • Suzuki, Hiroshi  ( Uonuma-Kikan Hospital , Minamiuonuma , Japan )
  • Numano, Fujito  ( Niigata University , Niigata , Japan )
  • Ono, Hiroshi  ( National Center for CH and D , Tokyo , Japan )
  • Ebata, Ryota  ( CHIBA KAIHIN MUNICIPAL HOSPITAL , Chiba , Japan )
  • Hamada, Hiromichi  ( Chiba University , Chiba , Japan )
  • Ueno, Kentaro  ( Kagoshima University , Kagoshima , Japan )
  • Watanabe, Kenichi  ( Nagaoka Red Cross Hospital , Nagaoka , Japan )
  • Uchida, Keiko  ( Keio University School of Medicine , Tokyo , Japan )
  • Tahara, Masahiro  ( Tsuchiya General Hospital , Hiroshima , Japan )
  • Toyono, Manatomo  ( AKITA UNIVERSITY , Akita , Japan )
  • Harada, Masako  ( Miyazaki University , Miyazaki , Japan )
  • Kuranobu, Hiroki  ( Tottori Chuo Hospital , Tottori , Japan )
  • Takahashi, Shin  ( Iwate Medical University , Iwate , Japan )
  • Ikeda, Kentaro  ( Gumma Children’s Hospital , Gumma , Japan )
  • Shiono, Junko  ( Ibaragi Children’s Hospital , Ibaragi , Japan )
  • Kuwabara, Naoki  ( Gifu Prefectural Medical Center , Gifu , Japan )
  • Maeda, Jun  ( TMCMC , Tokyo , Japan )
  • Waki, Kenji  ( Kurashiki Central Hospital , Kurashiki , Japan )
  • Inai, Kei  ( TOKYO WOMEN'S MEDICAL UNIVERSITY , Tokyo , Japan )
  • Baba, Shiro  ( Kyoto University, Pediatrics , Kyoto city , Japan )
  • Mima, Takahiro  ( Otsu Red Cross Hospital , Otsu , Japan )
  • Yokogawa, Mari  ( Sasebo General Medical center , Sasebo , Japan )
  • Murakami, Takashi  ( Tsukuba University , Tsukuba , Japan )
  • Suda, Kenji  ( KURUME UNIVERSITY SCHOOL OF MEDICIN , Kurume City , Japan )
  • Onishi, Tatsuya  ( Shikoku Medical Center for Children and Adults , Kagawa , Japan )
  • Toda, Takako  ( Yamanashi University , Yamanashi , Japan )
  • Hoshino, Shinsuke  ( SHIGA UNIVERCITY OF MEDICAL SCIENCE , Otsu , Japan )
  • Hasuwa, Tomoyuki  ( Nagasaki University , Nagasaki , Japan )
  • Yamamoto, Masaki  ( Kochi University , Kochi , Japan )
  • Harada, Gen  ( TOKYO WOMEN'S MEDICAL UNIVERSITY , Tokyo , Japan )
  • Higashi, Kouji  ( Department of Pediatr , Chiba , Japan )
  • Hokosaki, Tatsunori  ( Yokohama City University , Yokohama , Japan )
  • Kumamoto, Takashi  ( Saga University , Saga , Japan )
  • Awano, Hiroki  ( Yamagata University , Yamagata , Japan )
  • Takahashi, Tatsunori  ( Yamagata University , Yamagata , Japan )
  • Seki, Mitsuru  ( Jichi Medical University , Tochigi , Japan )
  • Yamagishi, Hiroyuki  ( Keio University School of Medicine , Tokyo , Japan )
  • Mitani, Yoshihide  ( MIE UNIVERSITY , Tsu Mie , Japan )
  • Takatsuki, Shinichi  ( Toho university Omori medical center , Tokyo , Japan )
  • Fukushima, Hiroyuki  ( Keio University School of Medicine , Tokyo , Japan )
  • Mitsushita, Norie  ( Shizuoka Children's Hospital , Shizuoka , Japan )
  • Ishida, Hidekazu  ( The University of Osaka , Suita , Japan )
  • Kogaki, Shigetoyo  ( The University of Osaka , Suita , Japan )
  • Author Disclosures:
    Hirofumi Sawada: DO have relevant financial relationships ; Speaker:Nippon Shinyaku:Expected (by end of conference) ; Research Funding (PI or named investigator): Janssen Pharmaceutical K.K.:Past (completed) | Koichi Sagawa: No Answer | Jun Muneuchi: DO NOT have relevant financial relationships | Tomotaka Nakayama: No Answer | Hiroshi Suzuki: No Answer | Fujito Numano: DO NOT have relevant financial relationships | Hiroshi Ono: DO NOT have relevant financial relationships | Ryota Ebata: DO NOT have relevant financial relationships | Hiromichi Hamada: DO NOT have relevant financial relationships | Kentaro Ueno: No Answer | Kenichi Watanabe: No Answer | Keiko Uchida: DO NOT have relevant financial relationships | Masahiro Tahara: No Answer | Manatomo Toyono: DO NOT have relevant financial relationships | Masako Takahashi: DO NOT have relevant financial relationships | hiroki kuranobu: DO NOT have relevant financial relationships | Shin Takahashi: No Answer | Kentaro Ikeda: DO NOT have relevant financial relationships | Junko Shiono: No Answer | Naoki Kuwabara: No Answer | Jun Maeda: DO NOT have relevant financial relationships | Kenji Waki: No Answer | Kei Inai: DO NOT have relevant financial relationships | Shiro Baba: DO NOT have relevant financial relationships | ?? ??: DO NOT have relevant financial relationships | Mari Yokogawa: No Answer | Takashi Murakami: No Answer | Kenji Suda: DO NOT have relevant financial relationships | Tatsuya Onishi: No Answer | Takako Toda: No Answer | Shinsuke Hoshino: DO NOT have relevant financial relationships | Tomoyuki Hasuwa: No Answer | Masaki Yamamoto: No Answer | Gen Harada: DO NOT have relevant financial relationships | Kouji Higashi: DO NOT have relevant financial relationships | Tatsunori Hokosaki: No Answer | takashi kumamoto: DO NOT have relevant financial relationships | Hiroki Awano: No Answer | tatsunori takahashi: DO NOT have relevant financial relationships | Mitsuru Seki: DO NOT have relevant financial relationships | Hiroyuki Yamagishi: DO NOT have relevant financial relationships | Yoshihide Mitani: No Answer | Shinichi Takatsuki: DO NOT have relevant financial relationships | hiroyuki fukushima: No Answer | Norie Mitsushita: DO NOT have relevant financial relationships | Hidekazu Ishida: DO NOT have relevant financial relationships | Shigetoyo Kogaki: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Clinical Challenges in Pulmonary Hypertension

Sunday, 11/09/2025 , 11:50AM - 01:00PM

Moderated Digital Poster Session

More abstracts on this topic:
9-Year Longitudinal Assessment of the 12-lead Electrocardiogram of Volunteer Firefighters

Bae Alexander, Dzikowicz Dillon, Lai Chi-ju, Brunner Wendy, Krupa Nicole, Carey Mary, Tam Wai Cheong, Yu Yichen

Altered Left Ventricular Hemodynamic Forces in Transposition of Great Arteries Following Arterial Switch Operation

Gaviria Susana, Kollar Sarah, Capuano Francesco, Loke Yue-hin

More abstracts from these authors:
The Japanese nationwide survey of the anomalous aortic origin of a coronary artery in children over 20 years

Suda Kenji, Kurosaki Kenichi, Yamakawa Yuki, Nii Masaki, Nakagawa Naomi, Ikeda Kentaro, Uyeda Tomomi, Hirono Keiichi, Suzuki Hiroyuki, Kuraoka Ayako

Comprehensive Genetic Analyses Combined with Animal Studies Provide New Insights into Genetic Modes of Outflow Tract Defects: A Large-Scale Japanese Investigation

Inoue Tadashi, Inai Kei, Terada Makiko, Azuma Kenko, Akagawa Hiroyuki, Yamagishi Hiroyuki, Uchida Keiko, Kodo Kazuki, Suzuki Nobuhide, Tsukamoto Satoshi, Mizushima Noboru, Greskovich Sarah, Garg Vidu, Furutani Yoshiyuki

You have to be authorized to contact abstract author. Please, Login
Not Available